Home>
US Stocks>
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals share price today

(ARWR)

Arrowhead Pharmaceuticals share price is $18.8 & ₹1,610.22 as on 1 Jan 2025, 2.30 'hrs' IST

$18.8

▲

0.19

(1.02%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Arrowhead Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Arrowhead Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Arrowhead Pharmaceuticals. Get details on the Indian mutual funds that are investing in Arrowhead Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Arrowhead Pharmaceuticals's financials.

Arrowhead Pharmaceuticals share price movements

Today's Low: $18.25
Today's High: $19.11
$18.80
2.91%
Downside
Day's Volatility :4.48%
Upside
1.62%
52 Weeks Low: $17.05
52 Weeks High: $39.83
$18.80
9.31%
Downside
52 Weeks Volatility :57.19%
Upside
52.8%

Arrowhead Pharmaceuticals Returns

Period	Arrowhead Pharmaceuticals, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-0.27%	-10.0%	0.0%
6 Months	-26.48%	-4.7%	0.0%
1 Year	-41.19%	-0.9%	0.0%
3 Years	-73.13%	-2.4%	-21.2%

Arrowhead Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$18.61
Open	$18.78
Today's High	$19.11
Today's Low	$18.253
Market Capitalization	$2.3B
Today's Volume	$1.2M
52 Week High	$39.83
52 Week Low	$17.05
Revenue TTM	$19.6M
EBITDA	$-529.8M
Earnings Per Share (EPS)	$-5.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.1%
Return On Equity TTM	-151.84%

How to invest in Arrowhead Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Arrowhead Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Arrowhead Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Arrowhead Pharmaceuticals or ARWR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Arrowhead Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Arrowhead Pharmaceuticals shares which would translate to 0.046 fractional shares of Arrowhead Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Arrowhead Pharmaceuticals, in just a few clicks!

Returns in Arrowhead Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Arrowhead Pharmaceuticals investment value today

Current value as on today

₹61,672

Returns

₹38,328

(-38.33%)

Returns from Arrowhead Pharmaceuticals Stock

₹41,195 (-41.19%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Arrowhead Pharmaceuticals

-55%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Arrowhead Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Jan 2, 2025. -55% less investors are searching Arrowhead Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Arrowhead Pharmaceuticals

BlackRock Inc
12.60%
Vanguard Group Inc
9.83%
venBio Select Advisor LLC
7.14%
State Street Corp
5.11%
FMR Inc
4.88%
Slate Path Capital LP
3.93%

Analyst Recommendation on Arrowhead Pharmaceuticals

Buy

75%Buy

25%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Arrowhead Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Arrowhead Pharmaceuticals

What analysts predicted

Upside of 152.66%

Current:

$18.80

Target:

$47.50

Insights on Arrowhead Pharmaceuticals

Price Movement
In the last 1 month, ARWR stock has moved down by -28.6%
Decreasing Revenue
Revenue is down for the last 2 quarters, 16.09M → 3.55M (in $), with an average decrease of 77.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -170.79M → -170.53M (in $), with an average increase of 0.2% per quarter
ARWR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 60.1%
ARWR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 110.4%
Price to Sales
ForARWR every $1 of sales, investors are willing to pay $110.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Arrowhead Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Arrowhead Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Arrowhead Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Arrowhead Pharmaceuticals, Inc.	-27.89%	-26.48%	-41.19%	-73.13%	-68.37%
Regeneron Pharmaceuticals, Inc.	-4.97%	-31.12%	-22.37%	13.59%	91.62%
Biontech Se	-1.42%	42.28%	3.53%	-50.85%	155.61%
Alnylam Pharmaceuticals, Inc.	-6.56%	-6.26%	23.43%	35.31%	102.91%
Vertex Pharmaceuticals Incorporated	-11.88%	-15.14%	-1.95%	80.96%	79.75%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Arrowhead Pharmaceuticals, Inc.	NA	NA	-1.32	-3.36	-1.52	-0.41	NA	2.66
Regeneron Pharmaceuticals, Inc.	17.61	17.61	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Arrowhead Pharmaceuticals, Inc.	Buy	$2.3B	-68.37%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.3B	91.62%	17.61	33.61%
Biontech Se	Buy	$27.3B	155.61%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	102.91%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$103.7B	79.75%	32.84	-4.51%

Arrowhead Pharmaceuticals Dividend announcements

Arrowhead Pharmaceuticals Earnings
Arrowhead Pharmaceuticals’s price-to-earnings ratio stands at None
Read More

About Arrowhead Pharmaceuticals

arrowhead pharmaceuticals is a clinical stage, nasdaq listed (ticker arwr) company developing medicines that treat intractable diseases by silencing the genes that cause them. using a broad portfolio of rna chemistries and efficient modes of delivery, our therapies trigger the rna interference mechanism to induce rapid, deep and durable knockdown of target genes. rna interference, or rnai, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. our rnai-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. our targeted rnai molecule (trimtm) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. the trim platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing

Organization	Arrowhead Pharmaceuticals
Employees	525
CEO	Dr. Christopher R. Anzalone Ph.D.
Industry	Health Technology

Management People of Arrowhead Pharmaceuticals

Name	Title
Dr. Christopher R. Anzalone Ph.D.	CEO, President & Director
Mr. Kenneth A. Myszkowski CPA, CPA, MBA	Chief Financial Officer
Mr. Patrick O'Brien J.D., PharmD	COO, General Counsel & Secretary
Dr. James C. Hamilton M.D., MBA	Chief of Discovery & Translational Medicine
Dr. Mark M. Davis Ph.D.	Founder and Founder & Director of Insert Therapeutics Inc & Calando
Dr. Vincent Anzalone CFA	Head of Investor Relations & VP
Mr. Howard Lovy	Director of Communications
Dr. Bruce D. Given M.D.	Chief Medical Scientist
Dr. Mark Seefeld	Head of Toxicology & VP
Aaron Tan	Head of Tax

Important FAQs about investing in Arrowhead Pharmaceuticals from India :

What is Arrowhead Pharmaceuticals share price today?

Arrowhead Pharmaceuticals share price today stands at $18.80, Open: $18.78 ; Previous Close: $18.61 ; High: $19.11 ; Low: $18.25 ; 52 Week High: $39.83 ; 52 Week Low: $17.05. The stock opens at $18.78, after a previous close of $18.61. The stock reached a daily high of $19.11 and a low of $18.25, with a 52-week high of $39.83 and a 52-week low of $17.05.

Can Indians buy Arrowhead Pharmaceuticals shares?

Yes, Indians can invest in the Arrowhead Pharmaceuticals (ARWR) from India.

With INDmoney, you can buy Arrowhead Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Arrowhead Pharmaceuticals at zero transaction cost.

How can I buy Arrowhead Pharmaceuticals shares from India?

It is very easy to buy Arrowhead Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Arrowhead Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Arrowhead Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Arrowhead Pharmaceuticals stocks?

To start investing in Arrowhead Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.